EGS Healthcare Capital Partners

Total investments

10

Average round size

49M

Portfolio companies

8

Rounds per year

0.43

Lead investments

1

Follow on index

0.20

Exits

6

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyOther Healthcare Technology SystemsHealth CareWellnessGeneticsManufacturingMedical DeviceMedicalPharmaceuticalClinical Trials

Summary

EGS Healthcare Capital Partners is the famous VC, which was founded in 1999. The main office of represented VC is situated in the Norwalk. The fund was located in North America if to be more exact in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical Device, Health Care. Among the most popular portfolio startups of the fund, we may highlight OptiScan Biomedical, Ardais Corporation, Endius. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.

This EGS Healthcare Capital Partners works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2007. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2005.

The current fund was established by Stefano Ciampolini, Terry Vance.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the EGS Healthcare Capital Partners, startups are often financed by Advanced Technology Ventures, Venture Capital Fund of New England, Hillman Medical Ventures. The meaningful sponsors for the fund in investment in the same round are NGN Capital, MedVenture Associates, The Carlyle Group. In the next rounds fund is usually obtained by Morgan Stanley Expansion Capital, MedVenture Associates, Wexford Capital.

Show more

Investments analytics

Analytics

Total investments
10
Lead investments
1
Exits
6
Rounds per year
0.43
Follow on index
0.20
Investments by industry
  • Health Care (9)
  • Medical (7)
  • Medical Device (5)
  • Biotechnology (4)
  • Wellness (2)
  • Show 6 more
Investments by region
  • United States (9)
Peak activity year
2005
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
87M
Group Appearance index
1.00
Avg. company exit year
10
Avg. multiplicator
2.78
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Jazz Pharmaceuticals 24 Mar 2004 Biotechnology, Health Care, Pharmaceutical Early Stage Venture 250M United States, California, Palo Alto

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.